Lingmin Yuan

752 total citations
20 papers, 453 citations indexed

About

Lingmin Yuan is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Lingmin Yuan has authored 20 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Lingmin Yuan's work include Ubiquitin and proteasome pathways (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Lingmin Yuan is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Lingmin Yuan collaborates with scholars based in China, United States and South Korea. Lingmin Yuan's co-authors include Shaun K. Olsen, Zongyang Lv, Su Zeng, Katelyn Williams, Haina Wang, Lushan Yu, Yanqing Liu, Yuan Chen, Yongsheng Xiao and Qinqin Yu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Lingmin Yuan

17 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingmin Yuan China 12 319 178 70 39 36 20 453
Fabienne Z. Gaugaz Sweden 7 212 0.7× 157 0.9× 68 1.0× 63 1.6× 42 1.2× 13 471
Lydia Aschauer Austria 13 321 1.0× 118 0.7× 40 0.6× 55 1.4× 24 0.7× 17 568
YiQing Lü China 9 190 0.6× 93 0.5× 103 1.5× 27 0.7× 17 0.5× 19 377
Darren Bentley Switzerland 12 272 0.9× 146 0.8× 25 0.4× 15 0.4× 35 1.0× 24 532
Edward J. Andress United Kingdom 7 144 0.5× 163 0.9× 22 0.3× 34 0.9× 59 1.6× 8 336
Luxing Pan United States 9 150 0.5× 213 1.2× 33 0.5× 30 0.8× 77 2.1× 13 394
Noah Younger United States 4 164 0.5× 89 0.5× 27 0.4× 35 0.9× 42 1.2× 7 367
Donna L. Fackenthal United States 13 409 1.3× 238 1.3× 73 1.0× 88 2.3× 15 0.4× 14 697
Mohan V. Chari United States 12 139 0.4× 126 0.7× 63 0.9× 43 1.1× 45 1.3× 19 476
Lisa Elkin United States 8 130 0.4× 158 0.9× 54 0.8× 43 1.1× 19 0.5× 13 325

Countries citing papers authored by Lingmin Yuan

Since Specialization
Citations

This map shows the geographic impact of Lingmin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingmin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingmin Yuan more than expected).

Fields of papers citing papers by Lingmin Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingmin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingmin Yuan. The network helps show where Lingmin Yuan may publish in the future.

Co-authorship network of co-authors of Lingmin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Lingmin Yuan. A scholar is included among the top collaborators of Lingmin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingmin Yuan. Lingmin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
5.
Yuan, Lingmin, Zongyang Lv, Digant Nayak, et al.. (2022). Crystal structures reveal catalytic and regulatory mechanisms of the dual-specificity ubiquitin/FAT10 E1 enzyme Uba6. Nature Communications. 13(1). 4880–4880. 9 indexed citations
6.
Luo, Zhenwu, Min Li, Zongyang Lv, et al.. (2022). Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection. mBio. 13(1). e0197921–e0197921. 3 indexed citations
7.
Yuan, Lingmin, et al.. (2021). Crystal structures of an E1–E2–ubiquitin thioester mimetic reveal molecular mechanisms of transthioesterification. Nature Communications. 12(1). 2370–2370. 22 indexed citations
8.
Lv, Zongyang, Lingmin Yuan, Katelyn Williams, et al.. (2018). Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme. Nature Communications. 9(1). 5145–5145. 47 indexed citations
9.
Lv, Zongyang, et al.. (2018). Crystal structure of a human ubiquitin E1–ubiquitin complex reveals conserved functional elements essential for activity. Journal of Biological Chemistry. 293(47). 18337–18352. 48 indexed citations
10.
Yuan, Lingmin, et al.. (2017). Structural insights into the mechanism and E2 specificity of the RBR E3 ubiquitin ligase HHARI. Nature Communications. 8(1). 211–211. 51 indexed citations
11.
Li, Li, et al.. (2017). The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. Acta Pharmacologica Sinica. 38(8). 1184–1194. 22 indexed citations
12.
Lv, Zongyang, Kimberly A. Rickman, Lingmin Yuan, et al.. (2017). S. pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity. Molecular Cell. 65(4). 699–714.e6. 40 indexed citations
13.
Lv, Zongyang, et al.. (2017). Domain alternation and active site remodeling are conserved structural features of ubiquitin E1. Journal of Biological Chemistry. 292(29). 12089–12099. 24 indexed citations
14.
Liu, Yanqing, et al.. (2016). Dimerization of human uridine diphosphate glucuronosyltransferase allozymes 1A1 and 1A9 alters their quercetin glucuronidation activities. Scientific Reports. 6(1). 23763–23763. 13 indexed citations
15.
Yuan, Lingmin, et al.. (2016). Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9 and 2B7 and Impacts on Glucuronidation Activity. Scientific Reports. 6(1). 34450–34450. 16 indexed citations
16.
Liu, Yanqing, Qinqin Yu, Hua Wang, et al.. (2016). Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin. Science Translational Medicine. 8(348). 348ra97–348ra97. 81 indexed citations
17.
18.
Wang, Haina, Lingmin Yuan, & Su Zeng. (2011). Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochemical Pharmacology. 82(11). 1757–1763. 40 indexed citations
19.
20.
Yuan, Lingmin, et al.. (1998). [Screening mutations in phenylketonuria by means of nonradioactive reverse dot blot hybridization].. PubMed. 15(5). 307–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabienne Z. Gaugaz Breakdown of academic impact, for papers by Lydia Aschauer Breakdown of academic impact, for papers by YiQing Lü Breakdown of academic impact, for papers by Darren Bentley Breakdown of academic impact, for papers by Edward J. Andress Breakdown of academic impact, for papers by Luxing Pan Breakdown of academic impact, for papers by Noah Younger Breakdown of academic impact, for papers by Donna L. Fackenthal Breakdown of academic impact, for papers by Mohan V. Chari Breakdown of academic impact, for papers by Lisa Elkin
Rankless by CCL
2026